Unknown

Dataset Information

0

Preclinical and clinical data for factor Xa and "universal" reversal agents.


ABSTRACT: Oral Factor Xa (FXa) inhibitors, a growing class of direct-acting anticoagulants, are frequently used to prevent stroke and systemic embolism in patients with atrial fibrillation and to prevent and treat venous thromboembolism. These drugs reduce the risk of clotting at the expense of increasing the risk of bleeding, and currently they have no specific reversal agent. However, andexanet alfa, a recombinant modified FXa decoy molecule, is in a late-phase clinical trial in bleeding patients, and ciraparantag, a small molecule that appears to reverse many anticoagulants including the FXa inhibitors, is in development. This review summarizes the published data to date on both drugs, which have the potential to change the management approach to patients with FXa inhibitoreassociated major hemorrhage.

SUBMITTER: Milling TJ 

PROVIDER: S-EPMC5568758 | biostudies-literature | 2016 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Preclinical and clinical data for factor Xa and "universal" reversal agents.

Milling Truman J TJ   Kaatz Scott S  

The American journal of emergency medicine 20160928 11S


Oral Factor Xa (FXa) inhibitors, a growing class of direct-acting anticoagulants, are frequently used to prevent stroke and systemic embolism in patients with atrial fibrillation and to prevent and treat venous thromboembolism. These drugs reduce the risk of clotting at the expense of increasing the risk of bleeding, and currently they have no specific reversal agent. However, andexanet alfa, a recombinant modified FXa decoy molecule, is in a late-phase clinical trial in bleeding patients, and c  ...[more]

Similar Datasets

| S-EPMC5568764 | biostudies-literature
| S-EPMC7149769 | biostudies-literature
| S-EPMC5597622 | biostudies-literature
| S-EPMC4230282 | biostudies-literature
| S-EPMC3297681 | biostudies-other
| S-EPMC8322590 | biostudies-literature
| S-EPMC5054289 | biostudies-literature
| S-EPMC8733676 | biostudies-literature
| S-EPMC10297422 | biostudies-literature